ATE46512T1 - Verfahren zur synthese von pyridoimidazorifamycin. - Google Patents

Verfahren zur synthese von pyridoimidazorifamycin.

Info

Publication number
ATE46512T1
ATE46512T1 AT85104790T AT85104790T ATE46512T1 AT E46512 T1 ATE46512 T1 AT E46512T1 AT 85104790 T AT85104790 T AT 85104790T AT 85104790 T AT85104790 T AT 85104790T AT E46512 T1 ATE46512 T1 AT E46512T1
Authority
AT
Austria
Prior art keywords
pyridoimidazorifamycin
synthesis
methods
Prior art date
Application number
AT85104790T
Other languages
English (en)
Inventor
Vincenzo Cannata
Gian Franco Tamagnone
Silvano Piani
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Application granted granted Critical
Publication of ATE46512T1 publication Critical patent/ATE46512T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85104790T 1984-05-15 1985-04-19 Verfahren zur synthese von pyridoimidazorifamycin. ATE46512T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT03463/84A IT1199374B (it) 1984-05-15 1984-05-15 Processo per la preparazione di pirido-imidazo-rifamicine
EP85104790A EP0161534B1 (de) 1984-05-15 1985-04-19 Verfahren zur Synthese von Pyridoimidazorifamycin

Publications (1)

Publication Number Publication Date
ATE46512T1 true ATE46512T1 (de) 1989-10-15

Family

ID=11107845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85104790T ATE46512T1 (de) 1984-05-15 1985-04-19 Verfahren zur synthese von pyridoimidazorifamycin.

Country Status (18)

Country Link
US (1) US4557866A (de)
EP (1) EP0161534B1 (de)
JP (1) JPS60252483A (de)
AR (1) AR241913A1 (de)
AT (1) ATE46512T1 (de)
AU (1) AU568934B2 (de)
CA (1) CA1215708A (de)
DE (1) DE3573120D1 (de)
DK (1) DK162647C (de)
ES (1) ES8603489A1 (de)
FI (1) FI81101C (de)
GR (1) GR851144B (de)
IE (1) IE58392B1 (de)
IT (1) IT1199374B (de)
NO (1) NO164242C (de)
PH (1) PH22007A (de)
PT (1) PT80446B (de)
ZA (1) ZA852971B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
DK1698630T3 (da) 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8987292B2 (en) 2006-03-09 2015-03-24 Salix Pharmaceuticals, Ltd. Rifaximin anti-rectal dysfunction preparation
PT2054066E (pt) 2006-08-02 2015-07-16 Salix Pharmaceuticals Inc Métodos para tratamento de enterite por radiação
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
US8633234B2 (en) * 2006-09-22 2014-01-21 Cipla Limited Rifaximin
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
SG10201607926VA (en) * 2008-02-25 2016-11-29 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
KR20100122937A (ko) 2008-02-26 2010-11-23 샐릭스 파마슈티컬스 리미티드 장 질환의 치료 방법
AU2009244190B2 (en) 2008-05-07 2016-02-25 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
CN101585843B (zh) * 2008-05-21 2011-07-06 重庆赛诺生物药业股份有限公司 一种利福昔明的制备工艺
US20110035232A1 (en) 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
ES2770308T3 (es) 2008-10-02 2020-07-01 Salix Pharmaceuticals Ltd Procedimientos de tratamiento de encefalopatía hepática
US7928115B2 (en) * 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
KR20110107806A (ko) 2008-12-10 2011-10-04 시플라 리미티드 리팍시민 복합체
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
BRPI1010028A2 (pt) 2009-06-02 2019-02-12 Salix Pharmaceuticals, Ltd. métodos de tratamento de encefalopatia hepática
EP2475392A4 (de) 2009-09-13 2013-01-09 Salix Pharmaceuticals Ltd Verfahren zur behandlung des reizdarmsyndroms
KR20120117788A (ko) 2009-11-23 2012-10-24 시플라 리미티드 국소용 폼 조성물
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
EP3650022A1 (de) 2010-02-18 2020-05-13 Salix Pharmaceuticals, Ltd. Verfahren zur behandlung von rifampin-resistenten clostridium difficilis-infektionen
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CA2802874A1 (en) * 2010-06-16 2011-12-22 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
EP3750526A1 (de) 2010-07-12 2020-12-16 Salix Pharmaceuticals, Inc. Formulierungen von rifaximin und anwendungen davon
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
MX350448B (es) 2011-02-11 2017-09-07 Salix Pharmaceuticals Ltd Formas de rifaximina y usos de las mismas.
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
WO2012155981A1 (en) 2011-05-19 2012-11-22 Friulchem Spa New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
PL2773205T3 (pl) 2011-11-02 2024-09-02 Salix Pharmaceuticals, Inc. Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
CA2876737A1 (en) 2012-06-13 2013-12-19 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014140988A1 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Rifaximin for use in the treating of vaginal infections.
EP2971062A2 (de) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Verfahren zur diagnose von vaginalinfektionen
ES2829285T3 (es) 2013-04-12 2021-05-31 Alfasigma Spa Administración de AINE y composiciones, métodos y sistemas relacionados
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ITMI20131307A1 (it) 2013-08-02 2015-02-02 A M S A Anonima Materie Sint & Affini S P A Processo per la preparazione di refaximina k
CN103509038B (zh) * 2013-09-30 2016-01-20 浙江思贤制药有限公司 一种新晶型利福昔明ζ及其制备方法
EP2927235B1 (de) 2014-03-31 2017-02-08 Euticals S.P.A. Polymorphe Mischung von Rifaximin und ihre Verwendung zur Herstellung fester Formulierungen
WO2015171493A1 (en) 2014-05-04 2015-11-12 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
PL3143027T3 (pl) 2014-05-12 2019-11-29 Alfasigma Spa Nowe solwatowane krystaliczne postaci rifaksyminy, ich wytwarzanie, kompozycje i zastosowania
EP2982764A1 (de) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identifizierung von Vaginalbakterien
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
EP4137132A1 (de) 2016-09-30 2023-02-22 Salix Pharmaceuticals, Inc. Feste dispersionsformen von rifaximin
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Also Published As

Publication number Publication date
PH22007A (en) 1988-05-02
EP0161534B1 (de) 1989-09-20
GR851144B (de) 1985-11-25
DE3573120D1 (en) 1989-10-26
DK162647B (da) 1991-11-25
EP0161534A2 (de) 1985-11-21
FI81101B (fi) 1990-05-31
AR241913A1 (es) 1993-01-29
ES543115A0 (es) 1986-01-01
IE851191L (en) 1985-11-15
DK214685D0 (da) 1985-05-14
NO851921L (no) 1985-11-18
DK162647C (da) 1992-04-13
AU4251585A (en) 1985-11-21
PT80446B (pt) 1987-11-11
IE58392B1 (en) 1993-09-08
US4557866A (en) 1985-12-10
CA1215708A (en) 1986-12-23
NO164242B (no) 1990-06-05
ZA852971B (en) 1985-12-24
IT1199374B (it) 1988-12-30
DK214685A (da) 1985-11-16
ES8603489A1 (es) 1986-01-01
PT80446A (en) 1985-06-01
JPH0469634B2 (de) 1992-11-06
FI81101C (fi) 1990-09-10
AU568934B2 (en) 1988-01-14
NO164242C (no) 1990-09-12
EP0161534A3 (en) 1987-03-04
IT8403463A0 (it) 1984-05-15
FI851907L (fi) 1985-11-16
JPS60252483A (ja) 1985-12-13
FI851907A0 (fi) 1985-05-14

Similar Documents

Publication Publication Date Title
ATE46512T1 (de) Verfahren zur synthese von pyridoimidazorifamycin.
DE3578979D1 (de) Verfahren zur synthese von jodbenzol.
DE3687592D1 (de) Verfahren zur synthese von zeolithen.
DE3884658D1 (de) Verfahren zur Diamantsynthese.
DE3586516D1 (de) Verfahren zur herstellung von maleimiden.
DE3586161D1 (de) Verfahren zur synthese von ammoniak.
DE3586114D1 (de) Synthese von ammoniak.
DE3482556D1 (de) Synthese von silicophosphoaluminaten.
AT387020B (de) Verfahren zur synthese von pyrido-imidazo-rifamycinen
DE3767216D1 (de) Verfahren zur synthese von mono- oder dihydroxyfluoralkanen.
DE69201245D1 (de) Verfahren zur Synthese von Hydrogenoperfluoralkanen.
ATE88504T1 (de) Verfahren zur genetischen modifikation von pflanzen.
DE59206765D1 (de) Verfahren zur enzymatischen Synthese von 2-Desoxy-beta-D-galactosiden
DE68915810D1 (de) Verfahren zur Synthese von Carboxamiden.
DE3584804D1 (de) Verfahren zur oxydation von alkanen.
DE3678734D1 (de) Verfahren zur chiralen synthese von 1-beta-methyl-carbapenem-zwischenprodukten.
DE3862381D1 (de) Verfahren zur oxydehydrierung von polyglykolmonoaethern zu den entsprechenden aldehyden.
DE3785812D1 (de) Verfahren zur zuechtung von safranstigmageweben.
DE69114657D1 (de) Verfahren zur Synthese von Monohalogenalkylferrocenen.
EP0018420A4 (de) Verfahren zur synthese von harnstoff.
FI850594A7 (fi) Perfluorialkaanikarboksyylihappojen synteesi.
ATE92467T1 (de) Verfahren zur synthese von n-methyl-3,4dimethoxyphenylethylamin.
DE69019839D1 (de) Verfahren zur Synthese von cis-Olefinen.
PT87551A (pt) Verfahren zur behandlung von fadenfoermigel textilgut
DE3575556D1 (de) Verfahren zur herstellung von 2-phenylbenztriazolen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time